WeVote

Bill

Bill

HB 885

Newborn screening program; include cytomegalovirus (CMV) in conditions tested for.

2026 Regular Session Introduced by Steve Horne

Requires Mississippi newborns be screened for cytomegalovirus to enable early detection and treatment of the most common congenital infection.

Referred To Public Health and Human Services
0
WeVote Research Nonpartisan
Bill Summary · HB 885

Legislative bill overview

HB 885 would expand Mississippi's newborn screening program to include testing for cytomegalovirus (CMV), a common virus that can cause serious health complications in newborns if left undetected. The bill mandates that CMV screening be added to the panel of conditions tested for in all newborns before hospital discharge or within the required screening timeframe.

Why is this important

CMV is the most common congenital infection in the United States, affecting approximately 1 in 200 newborns, yet many states do not routinely screen for it. Early detection allows for prompt intervention and treatment, which can prevent or reduce hearing loss, developmental delays, and other serious complications. Adding CMV to Mississippi's screening program could identify affected infants early enough to begin antiviral therapy and implement interventions that significantly improve long-term health outcomes.

Potential points of contention

  • Cost and implementation: Expanding screening programs requires additional laboratory resources, training, and funding; questions may arise about who bears these costs and whether funding mechanisms are adequately addressed
  • Test accuracy and false positives: CMV screening in newborns can produce false positives requiring confirmatory testing, which may cause parental anxiety and increase healthcare system burden
  • Medical necessity debate: Some may argue the cost-benefit ratio doesn't justify universal screening, though medical organizations increasingly recommend it

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.